Status:

RECRUITING

"Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis"

Lead Sponsor:

Hospital Civil de Guadalajara

Conditions:

Knee Osteoarthritis

Osteoarthritis

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

This randomized, double-blind clinical trial aims to evaluate the effect of high-intensity pulsed electromagnetic field therapy (HI-PEMF) applied either exclusively on the knee joint or bimodally on t...

Detailed Description

Knee osteoarthritis (OA) is a highly prevalent and disabling condition in older adults. It often coexists with quadriceps muscle weakness, sarcopenia, and frailty, all of which contribute to pain, fun...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age ≥ 60
  • Clinical and radiological diagnosis of knee OA grade I-IV
  • Pain ≥ 3 on Numeric Analog Scale for \>6 months
  • Can walk (with/without aid)
  • Cognitive ability to follow instructions
  • Signed informed consent
  • Availability for 9 treatment sessions and home exercise Exclusion Criteria
  • Prior total knee arthroplasty (unilateral or bilateral)
  • Neurological disorders affecting motor function or cognition (e.g., Parkinson's disease, stroke, moderate to severe dementia)
  • Active inflammatory rheumatic diseases (e.g., rheumatoid arthritis, lupus)
  • Presence of pacemakers, implantable defibrillators, or metallic implants near the treatment area
  • Current use of other physical therapy modalities for pain (e.g., electrotherapy, ultrasound, TENS) outside the study protocol
  • Participation in another clinical trial within the past 3 months
  • Current use of NSAIDs or systemic/local corticosteroids (including intra-articular injections)
  • Open wounds or active infections at the treatment site
  • Decompensated cardiac conditions or medical contraindication to exercise
  • Vestibular disorders that affect balance and interfere with functional assessments
  • Uncorrected visual impairment interfering with gait or balance (visual acuity worse than 20/60 in the better eye, assessed by Snellen chart)
  • Withdrawal Criteria:
  • Participants who complete fewer than 7 out of the 9 planned intervention sessions (i.e., less than 80% adherence)
  • Occurrence of serious adverse events related to the intervention that contraindicate continuation
  • Repeated non-compliance with the home exercise program, documented in at least two consecutive weekly follow-up reports
  • Voluntary withdrawal of consent at any time during the study

Exclusion

    Key Trial Info

    Start Date :

    September 15 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 15 2026

    Estimated Enrollment :

    64 Patients enrolled

    Trial Details

    Trial ID

    NCT07198750

    Start Date

    September 15 2025

    End Date

    April 15 2026

    Last Update

    September 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital Civil de Guadalajara "Fray Antonio Alcalde"

    Guadalajara, Jalisco, Mexico, 44280